United Kingdom · Question · Written question
UIN 100416
Sacituzumab Govitecan
Introduced
10 January 2022
Last action
18 January 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
18 January 2022
Summary
To ask the Secretary of State for Health and Social Care, if he will (a) provide an update on the discussions between NHS England and Gilead on an interim access arrangement for secondary breast cancer drug Trodelvy and (b) publish the timetable for the i
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
10 January 2022
Written question
To ask the Secretary of State for Health and Social Care, if he will (a) provide an update on the discussions between NHS England and Gilead on an interim access arrangement for secondary breast cancer drug Trodelvy and (b) publish the timetable for the i
Source: Commons
18 January 2022
Answer
NHS England and NHS Improvement and the National Institute for Health and Care Excellence (NICE) have agreed principles to allow potential interim access to medicines licensed through Project Orbis, where there is a gap between licensing and publication o...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-01-10/100416
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1401346
- uk · wq-1401346 · source updated 18 January 2022